Protein-Calorie Malnutrition in the Critically Ill Patient

1. Overview and Prevalence

• Poor wound healing
• Compromised immune status
• Impaired organ function
• Increased length of hospital stay and readmissions
• Higher mortality and increased healthcare costs

2. Two Distinct Diseases (Pathophysiological Classification)

a) Simple Starvation-Related Malnutrition (SRM)

• Occurs with low or absent food intake without significant inflammation
• Body adapts by progressively reducing metabolic rate
• Protein catabolism is relatively modest (~3–5 g N/day)
• Energy comes primarily from fat oxidation
• Body protein is preserved as long as energy needs are met by fat

b) Cytokine/Inflammation-Driven Malnutrition (CDM)

• Driven by systemic inflammation (e.g., sepsis, trauma, burns, major surgery)
• Characterized by obligatory, uncontrollable muscle protein catabolism
• A highly protein-catabolic patient may excrete ≥15 g N/day in urine even without dietary protein — more than three times faster than simple fasting
• Since 1 g N lost reflects 6.25 g protein: 15 g N/day = 94 g protein/day lost
• This is the form that dominates in the critically ill

3. Protein Requirements in the Critically Ill

• Healthy adult minimum: 0.65 g/kg/day; recommended: 0.80 g/kg/day
• Critically ill/highly catabolic patient: requirements are markedly increased, driven by:
  1. Increased amino acid losses (wound exudates, fistulas, inflammatory diarrhea, renal replacement therapy)
  2. Marked muscle protein catabolism from the metabolic response to systemic inflammation accompanying major injury, serious infections, and intense immune activation

• High-dose glucocorticoid therapy
• Sepsis, trauma, burns
• Renal replacement therapy (removes amino acids from circulation)

• Positive energy balance (extra carbohydrate) improves body protein retention
• Negative energy balance reduces efficiency of protein turnover and increases dietary protein requirements

4. Metabolic Response to Critical Illness

Key point: In patients with high-level inflammation (CRP >50 mg/L), nutrition care is primarily supportive, not therapeutic for correcting protein deficits. Anabolic nutrition goals become achievable only as inflammation subsides.

5. Diagnosis (GLIM Criteria, 2019)

• Non-volitional weight loss
• Low BMI
• Reduced muscle mass

• Reduced food intake or assimilation (≤50% of energy requirement for >1 week, OR any reduction >2 weeks)
• Disease burden/inflammatory condition — acute illness (major infection, burns, trauma, closed head injury) or chronic disease

• Mild inflammation: 3.0–9.9 mg/L
• Moderate: 10–50 mg/L
• Severe: >50 mg/L

Note: Albumin and prealbumin are unreliable markers of nutritional status in the presence of inflammation. They reflect acute-phase response, not protein stores.

6. Specialized Nutritional Support (SNS) in the Critically Ill

Indications for SNS

1. Nutrient ingestion will likely remain inadequate for many days
2. There is important muscle loss (of any cause)
3. Patient's nutrient requirements are increased (inflammatory/protein-catabolic state)
4. SNS has a reasonable prospect of improving clinical outcome or quality of life

Enteral Nutrition (EN) — Preferred Route

• Common in: impaired consciousness, severe dysphagia, mechanical ventilation

Intensive EN is best avoided during very grave and unstable illness.

• Nasogastric tube; head of bed raised to ≥30° to prevent aspiration
• Standard formula: start at 50 mL/h, advance by 25 mL/h every 4–8 h to goal rate
• Intragastric bolus option: 200–400 mL over 15–60 min with 4-hourly residual checks

• Aspiration pneumonia (most dangerous — especially in ventilated patients)
• Diarrhea, hyperglycemia, fluid/electrolyte derangements
• Failure to achieve nutritional goal

Parenteral Nutrition (PN) — When EN Not Feasible

• Contains: crystalline amino acids, glucose, lipid emulsions, minerals, electrolytes, micronutrients — infused directly into bloodstream
• Indicated when EN is contraindicated, impractical, or failing to meet nutritional goals

7. Refeeding Syndrome

• Carbohydrate refeeding → insulin secretion → cellular uptake of phosphate, potassium, magnesium
• Results in dangerous hypophosphatemia, hypokalemia, hypomagnesemia

1. Abrupt increase of intravascular volume (fluids + glucose → insulin-mediated renal Na retention)
2. Increased cardiac demand on an atrophic left ventricle (insulin-mediated ↑ resting energy expenditure)
3. Myocardial deficiencies of K, P, Mg

• Severely limit sodium provision
• Introduce carbohydrate slowly
• Monitor serum phosphate, potassium, magnesium frequently
• Provide appropriate electrolyte supplements

8. Special Clinical Situations in the ICU

Summary

Protein-Calorie Malnutrition (PCM) — Definition, Causes, Types, Clinical Features, Management

Definition

• Weight-to-height ratio ≥3 standard deviations below the median growth standard, OR
• Visible wasting, OR
• Presence of nutritional edema

• Somatic compartment — skeletal muscle proteins (depleted more in marasmus)
• Visceral compartment — liver and organ proteins (depleted more in kwashiorkor)

Causes

Primary Causes (Inadequate Intake)

Secondary Causes (Increased Loss / Demand)

Types

Type 1: Marasmus ("Dry" PCM)

• Caused by severe global caloric deficiency (both protein and energy)
• Somatic compartment predominantly affected
• Adaptive catabolism provides amino acids as energy
• Visceral proteins relatively spared → albumin normal or only slightly reduced
• Subcutaneous fat mobilized as fuel

Type 2: Kwashiorkor ("Wet" PCM)

• Caused by protein deprivation relatively greater than caloric reduction
• Carbohydrate-dominated diet (e.g., post-weaning)
• Visceral compartment severely depleted → marked hypoalbuminemia → edema
• Often precipitated by superimposed infection/acute stress

Type 3: Marasmic-Kwashiorkor (Mixed)

• Features of both types with wasting and edema
• Occurs when a severely wasted child develops an acute infectious illness

Type 4: Nutritional Dwarfism (Stunting)

• Chronic mild-to-moderate PCM
• Weight < 60% for age; normal weight-for-height
• Growth retardation without acute wasting

In Adults / Critically Ill (Harrison's Classification):

Waterlow Classification of Severity

Clinical Features

Fig. Childhood malnutrition. (A) Marasmus — severe muscle wasting and loss of subcutaneous fat; head appears too large. (B) Kwashiorkor — generalized edema (ascites, puffiness of face, hands, legs). — Robbins & Kumar Basic Pathology

Comparative Clinical Features

Features Common to Both Types

• Growth failure / weight loss
• Anemia — multifactorial (iron, folate, protein deficiency; anemia of chronic inflammation)
• Immune deficiency — particularly T-cell-mediated immunity → recurrent infections
• Vitamin deficiencies — vitamins A, C, folate, B12, zinc
• Hypothermia — due to loss of insulating subcutaneous fat and reduced metabolic rate
• Poor wound healing
• Bone marrow hypoplasia — reduced red cell precursors

Morphological Changes (Pathology)

• Liver: Fatty change in kwashiorkor (reduced apolipoprotein synthesis → VLDL impairment); not in marasmus
• Small intestine (kwashiorkor): Decreased crypt mitoses → mucosal atrophy, villous loss, disaccharidase deficiency
• Bone marrow: Hypoplastic; mixed anemia (microcytic, normocytic, or macrocytic)
• Brain (severe infantile PCM): Cerebral atrophy, reduced neurons, impaired myelination
• Thymus and lymphoid tissue: Atrophic (more in kwashiorkor)

In Critically Ill Adults (Harrison's)

• Hypoalbuminemia — marker of inflammation, not nutrition per se
• ECF expansion — edema may conceal the true degree of muscle wasting
• BMI unreliable in presence of edema/obesity
• Urinary nitrogen loss ≥15 g N/day in severe catabolic states → loss of ~94 g protein/day
• Low serum prealbumin — reflects systemic inflammation (not nutritional status)

Management

Step 1: Screening and Diagnosis

• Use validated screening tools (NRS-2002, MUST, MNA)
• Diagnose using GLIM criteria: ≥1 phenotypic + ≥1 etiologic criterion
• Assess severity: weight loss, BMI, muscle mass
• Identify underlying cause (inflammation vs. inadequate intake)

Step 2: Treat the Underlying Cause

• Manage infection, sepsis, trauma, malabsorption
• Modify drugs that impair nutrient absorption
• Address barriers to voluntary food intake (dysphagia, pain, nausea, depression)

Step 3: Nutritional Repletion

A. Optimized Voluntary Nutrition (First-line when feasible)

• Preferred — empowers patient, supports mobilization
• Address specific barriers: food texture, palatability, timing
• Oral nutritional supplements

B. Enteral Nutrition (EN) — preferred when gut is accessible

• Nasogastric tube; head of bed at ≥30°
• Polymeric formula: start at 50 mL/h, advance by 25 mL/h every 4–8 h to goal rate
• Intragastric bolus option: 200–400 mL every 4 h

C. Parenteral Nutrition (PN) — when EN not feasible

• Contains: crystalline amino acids + glucose + lipid emulsions + electrolytes + micronutrients
• Central PN for full caloric needs; peripheral PN for supplemental needs
• Indicated when EN is contraindicated, impractical, or failing to meet nutritional goals

Protein and Energy Targets

Step 4: Prevent and Manage Refeeding Syndrome

1. Abrupt expansion of intravascular volume (glucose → insulin → renal Na retention)
2. Increased cardiac demand on atrophic left ventricle
3. Myocardial K/P/Mg deficiency

Monitoring

• Serum electrolytes (especially phosphate, K, Mg) — daily during refeeding
• Nitrogen balance — if available
• BMI, muscle circumference
• CRP (tracks inflammation trajectory)
• Serum albumin — useful over weeks to months after inflammation resolves (t½ ~2 weeks)